Heyholder
‹ Disclosures

Investor Relations Event


AI summary · Not investment advice

Neoimmunetech will hold an IR presentation and Q&A for domestic analysts and institutional investors in Yeouido, Seoul, on November 4-5.

Key facts

IR period
Nov 4, 2026Start date 2026-11-04, end date 2026-11-05
Venue
Yeouido, Seoul
Audience
Domestic brokerage analysts and institutional investors, etc.
Purpose
Improve understanding of development status and management strategy
Format
Presentation and Q&A
Main topics
Explanation of R&D progress; explanation of technology transfer and Endari business progress, and Q&A
Sponsor
IR Curdus
Materials posting date
Nov 4, 2026
Materials location
Posted in the IR library of the KRX KIND system (https://kind.co.kr)
Show Korean comments

Comments

No comments yet

Comments from shareholders will appear here.